HIM
BVS icon

Hillsdale Investment Management’s Bioventus BVS Stock Holding History

Hillsdale Investment Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.57M Buy
907,739
+236,600
+35% +$2.26M 0.2% 136
2026
Q1 		$6.13M Buy
671,139
+401,230
+149% +$3.36M 0.17% 141
2025
Q4 		$2.01M Buy
+269,909
New +$1.94M 0.06% 326
2025
Q2 		– Sell
-27,442
Closed -$251K – 634
2025
Q1 		$251K Sell
27,442
-650
-2% -$6.49K 0.01% 407
2024
Q4 		$295K Sell
28,092
-3,100
-10% -$36.7K 0.01% 376
2024
Q3 		$373K Sell
31,192
-8,450
-21% -$73.1K 0.03% 357
2024
Q2 		$228K Buy
39,642
+4,900
+14% +$26.9K 0.02% 372
2024
Q1 		$181K Buy
34,742
+7,200
+26% +$35.2K 0.01% 384
2023
Q4 		$145K Buy
+27,542
New +$109K 0.01% 393

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hillsdale Investment Management's BVS Position: Q2 2026 in Review

Hillsdale Investment Management increased its Bioventus (BVS) stake by 35% in Q2 2026, buying an estimated $2.26M and bringing the position to 907,739 shares worth $8.57M. The position accounts for 0.2% of the portfolio, ranked #136.

Hillsdale Investment Management first reported a position in BVS in Q4 2023 and has held it in 9 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Hillsdale Investment Management held 907,739 shares of Bioventus worth $8.57M as of Q2 2026.
  • Hillsdale Investment Management bought 236,600 Bioventus shares in Q2 2026, an estimated $2.26M.
  • Bioventus made up 0.2% of Hillsdale Investment Management's portfolio in Q2 2026, its #136 holding.
  • Hillsdale Investment Management first reported a position in Bioventus in Q4 2023 and has held it in 9 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.